Stockscreener 앱 받기
2.17
1.36%
-0.03
시간 외 거래:
2.17
전일 마감가:
$2.20
열려 있는:
$2.2
하루 거래량:
33,276
Relative Volume:
0.04
시가총액:
$3.55M
수익:
$4.79M
순이익/손실:
$-13.42M
주가수익비율:
-0.8158
EPS:
-2.66
순현금흐름:
$-10.30M
1주 성능:
-22.50%
1개월 성능:
-34.64%
6개월 성능:
-33.64%
1년 성능:
-81.54%
1일 변동 폭
$1.9995
$2.2001
1주일 범위
$1.9995
$2.9757
52주 변동 폭
$1.9995
$12.11
Qualigen Therapeutics Inc Stock (QLGN) Company Profile
명칭
Qualigen Therapeutics Inc
전화
(760) 918-9165
주소
2042 CORTE DEL NOGAL, CALIFORNIA
QLGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QLGN
Qualigen Therapeutics Inc
|
2.17 | 3.60M | 4.79M | -13.42M | -10.30M | -2.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Qualigen Therapeutics Inc 주식(QLGN)의 최신 뉴스
How many analysts rate Qualigen Therapeutics Inc. as a “Buy”Capitalize on market trends with confidence - jammulinksnews.com
What catalysts could drive Qualigen Therapeutics Inc. stock higher in 2025Superior risk-adjusted returns - jammulinksnews.com
How does Qualigen Therapeutics Inc. generate profit in a changing economyPowerful growth strategies - jammulinksnews.com
How volatile is Qualigen Therapeutics Inc. stock compared to the marketAchieve breakthrough performance in the market - jammulinksnews.com
News impact scoring models applied to Qualigen Therapeutics Inc.Weekly Entry Signal Based Forecast Tool - newser.com
Evaluating Qualigen Therapeutics Inc. with trendline analysisLow Risk Strategy with Smart Entry Zones - newser.com
What analysts say about Qualigen Therapeutics Inc. stockFree Investment Portfolio Suggestions - jammulinksnews.com
Why is Qualigen Therapeutics Inc. stock attracting strong analyst attentionHigh-yield investments - jammulinksnews.com
When is Qualigen Therapeutics Inc. stock expected to show significant growthBuild wealth steadily with expert advice - jammulinksnews.com
What makes Qualigen Therapeutics Inc. stock price move sharplySuperior return velocity - jammulinksnews.com
What are the latest earnings results for Qualigen Therapeutics Inc.Extraordinary performance - jammulinksnews.com
What is Qualigen Therapeutics Inc. company’s growth strategyUncover the best stocks for explosive growth - jammulinksnews.com
Combining machine learning predictions for Qualigen Therapeutics Inc.Free Optimized Watchlist With Daily Adjustments - Newser
Full technical analysis of Qualigen Therapeutics Inc. stockSector-Wise Stock Strength Trend Analysis - Newser
How Qualigen Therapeutics Inc. stock performs during market volatilityIntraday Price Forecast Using Volume Models - Newser
What institutional investors are buying Qualigen Therapeutics Inc. stockPre Market Review For Consistent Profits - jammulinksnews.com
Can Qualigen Therapeutics Inc. Overcome Bearish SentimentShort Term High Yield Stock Tips for Active Traders - metal.it
Has Qualigen Therapeutics Inc. Stock Ever Crashed Historical Volatility ReviewReal Trader Watchlist of Hot Stocks Released - metal.it
Will Breakout in Qualigen Therapeutics Inc. Sustain Through Next WeekCapital Preserving Trade Plan Templates Shared - beatles.ru
Published on: 2025-07-31 11:14:48 - metal.it
Statistical indicators supporting Qualigen Therapeutics Inc.’s strengthFree Fast Gaining Stock Screener Report - Newser
Qualigen Therapeutics Secures Nasdaq Compliance Extension - MSN
Bollinger Band Squeeze Points to Volatility in Qualigen Therapeutics Inc.Weekly Chart Analysis With Entry Advice Provided - metal.it
Qualigen Therapeutics Raises $4.5 Million Through Series A-3 Preferred Stock Placement - AInvest
Is This the Dip to Buy in Qualigen Therapeutics Inc.Accurate Technical Trend Reversal Picks Detected - metal.it
Sector Leaders Rotate Capital Into Qualigen Therapeutics Inc.Real-Time Trade Insights Spark Market Reactions - metal.it
Qualigen Therapeutics Inc. Crosses 200 Day MA — Signal or NoiseTriple Return Setup With Risk Control Explained - metal.it
Is it the right time to buy Qualigen Therapeutics Inc. stockStock Market Entry Points To Watch Now - jammulinksnews.com
Qualigen Therapeutics Announces $4.5M Private Placement - MSN
Qualigen Therapeutics Granted Patents for Cancer Drug in More Than 20 European Countries - 富途牛牛
Qualigen Therapeutics raises $4.5 million through private placement of Series A-3 Preferred Stock. - AInvest
Qualigen's Strategic Turnaround and Nasdaq Compliance: A Credible Path to Long-Term Value - AInvest
Qualigen Therapeutics Provides Update on Nasdaq Communications and Continued Listing Status - The Manila Times
Qualigen Therapeutics' Nasdaq Compliance and Strategic Capital Raise: Assessing the Long-Term Viability of a Biotech in Crisis and Recovery - AInvest
Qualigen regains Nasdaq compliance with $4.5 million private placement By Investing.com - Investing.com Nigeria
Qualigen regains Nasdaq compliance with $4.5 million private placement - Investing.com Australia
Qualigen Therapeutics Updates on Nasdaq Communications and Listing Status - AInvest
Qualigen Secures Nasdaq Listing Status with $4.5M Strategic Funding, Addresses All Compliance Issues - Stock Titan
Published on: 2025-07-28 19:32:51 - metal.it
Qualigen Therapeutics Announces $4.5 Million Private Placement of Series A-3 Convertible Preferred Stock - The Manila Times
Qualigen Therapeutics Secures $4.5 Million Private Placement for Cancer Treatment Research - AInvest
Cancer Drug Developer Qualigen Secures $4.5M From Institutional Investors for Treatment Pipeline - Stock Titan
Combining machine learning predictions for Qualigen Therapeutics Inc. Long-Term Safety Investment Analysis Report - Newser
Qualigen Therapeutics Inc (QLGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
0.15%
자본화:
|
볼륨(24시간):